Sfoglia per Rivista VACCINE
A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies.
1995 Scodeller, Ea; Tisminetzky, Sg; Porro, F; Schiappacassi, M; DE ROSSI, Anita; Chiecco Bianchi, L; Baralle, Fe
A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees
2001 Schneider, J.; Langermans, J.; Gilbert, S.; Blanchard, T.; Twigg, S.; Naitza, S.; Hannan, C.; Aidoo, M.; Crisanti, A.; Robson, K. J. H.; Smith, G.; Hill, A.; Thomas, A.
Attenuated live infectious bronchitis virus QX vaccine disseminates slowly to target organs distant from the site of inoculation
2019 Laconi, A.; Weerts, E. A. W. S.; Bloodgood, J. C. G.; Deniz Marrero, J. P.; Berends, A. J.; Cocciolo, G.; de Wit, J. J.; Verheije, M. H.
Avian metapneumoviruses expressing Infectious Bronchitis virus genes are stable and induce protection
2013 Falchieri, M.; Lupini, C.; Cecchinato, Mattia; Catelli, E.; Kontolaimoub, M.; Naylor, C. J.
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study
2023 Willame, C; Dodd, C; Durán, Ce; Elbers, Rjhj; Gini, R; Bartolini, C; Paoletti, O; Wang, L; Ehrenstein, V; Kahlert, J; Haug, U; Schink, T; Diez-Domingo, J; Mira-Iglesias, A; Carreras, Jj; Vergara-Hernández, C; Giaquinto, C; Barbieri, E; Stona, L; Huerta, C; Martín-Pérez, M; García- Poza, P; de Burgos, A; Martínez-González, M; Bryant, V; Villalobos, F; Pallejà-Millán, M; Aragón, M; Carreras, Jj; Souverein, P; Thurin, Nh; Weibel, D; Klungel, Oh; Sturkenboom, Mcjm
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application
2001 Betti, M.; Voltan, R.; Marchisio, M.; Mantovani, I.; Boarini, C.; Nappi, F.; Ensoli, B.; Caputo, Antonella
Characterization of immune responses elicited in mice by intranasal co immunization with HIV-1 Tat, gp140 ΔV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin.
2008 Caputo, Antonella; BROCCA COFANO, E; Castaldello, Arianna; Voltan, R; Gavioli, R; Srivastava, Ik; Barnett, Sw; Cafaro, A; Ensoli, B.
Comment on the contribution by Weycker et al., "Cost of routine immunization of young children against rotavirus infection with Rotarix ® versus RotaTeq ®".
2010 Toumi, M; Vesikari, T; Giaquinto, Carlo
Comparison of three different influenza vaccines in institutionalised elderly
2001 Baldo, Vincenzo; Menegon, Tiziana; Bonello, C.; Floreani, Annarosa; Trivello, Renzo
Continued use of IBV 793B vaccine needs reassessment after its withdrawal led to the genotype's disappearance
2014 Franzo, Giovanni; Clive John, Naylor; Caterina, Lupini; Drigo, Michele; Elena, Catelli; Valeria, Listorti; Patrizia, Pesente; Davide, Giovanardi; Emilio, Morandini; Cecchinato, Mattia
Demonstration of loss of attenuation and extended field persistence of a live avian metapneumovirus vaccine
2006 Catelli, E; Cecchinato, Mattia; SAVAGE C., E; JONES R., C; Naylor, C. J.
Developing an epitope-driven tuberculosis (TB) vaccine
2005 DE GROOT, As; Mcmurry, J; Marcon, Luisa; Franco, J; Rivera, D; Kutzler, M; Weiner, D; Martin, B.
Differential polarization of immune responses by co-administration of antigens with chemokines.
2004 Frauenschuh, A; Devico, Al; Lim, Sp; Gallo, Rc; GARZINO DEMO, Alfredo
Distribution of invasive meningococcal B disease in Italian pediatric population: implications for vaccination timing.
2014 Azzari, C; Canessa, C; Lippi, F; Moriondo, M; Indolfi, G; Nieddu, F; Martini, M; de Martino, M; Castiglia, P; Baldo, Vincenzo; Resti, M; Italian Group for the Study of Invasive Bacterial, Disease
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune response and strongly enhance cellular responses of HIV-1 tat DNA vaccination.
2006 Castaldello, Arianna; BROCCA COFANO, E; Voltan, R; Triulzi, C; Altavilla, Giuseppe; Laus, M; Sparnacci, K; Ballestri, M; Tondelli, L; Fortin, C; Gavioli, R; Ensoli, B; Caputo, Antonella
Does yellow fever 17D vaccine protect against melanoma?
2009 Mastrangelo, Giuseppe; Krone, B; Fadda, Emanuela; Buja, Alessandra; Grange, Jm; Rausa, Giuseppe; DE VRIES, E; Koelmel, Kf
Effect of different vaccination strategies on IBV QX population dynamics and clinical outbreaks
2016 Franzo, Giovanni; Tucciarone, CLAUDIA MARIA; Blanco, Angela; Nofrarías, Miquel; Biarnés, Mar; Cortey, Marti; Majó, Natàlia; Catelli, Elena; Cecchinato, Mattia
Enhanced therapeutic effect of APAVAC immunotherapy in combination with dose-intense chemotherapy in dogs with advanced indolent B-cell lymphoma
2015 Marconato, L; Stefanello, D.; Sabattini, S.; Comazzi, S.; Riondato, F.; Laganga, P.; Frayssinet, P.; Pizzoni, S.; Rouquet, N.; Aresu, Luca
Evaluation of the immunogenicity and safety of Brucella melitensis B115 vaccination in pregnant sheep
2014 Pérez Sancho, M; Adone, R; García Seco, T; Tarantino, M; Diez Guerrier, A; Drumo, Rosanna; Francia, M; Domínguez, L; Pasquali, P; Álvarez, J.
Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses.
2006 Bozac, A; Berto, E; Vasquez, F; Grandi, P; Caputo, Antonella; Manservigi, R; Ensoli, B; Marconi, P.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile